PE20090693A1 - Derivados de quinolina como moduladores de gabaa - Google Patents

Derivados de quinolina como moduladores de gabaa

Info

Publication number
PE20090693A1
PE20090693A1 PE2008001052A PE2008001052A PE20090693A1 PE 20090693 A1 PE20090693 A1 PE 20090693A1 PE 2008001052 A PE2008001052 A PE 2008001052A PE 2008001052 A PE2008001052 A PE 2008001052A PE 20090693 A1 PE20090693 A1 PE 20090693A1
Authority
PE
Peru
Prior art keywords
ona
quinolin
aryl
amino
disorder
Prior art date
Application number
PE2008001052A
Other languages
English (en)
Inventor
Hui-Fang Chang
Marc Chapdelaine
Keith John Herzog
Carey Horchler
Richard Jon Schmiesing
Bruce Thomas Dembofsky
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40084145&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090693(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20090693A1 publication Critical patent/PE20090693A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A UN COMPUESTO DERIVADO DE QUINOLINA DE FORMULA (I), DONDE R1 ES ALQUILO C1-C6, ARILO C6-C10, CICLOALQUILO C3-C7, ENTRE OTROS; R2 ES H, ARILO C6-C10, ALQUILO C1-C6, -C(=O)Rb, ENTRE OTROS; Rb ES H, HALOALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R3, R4 Y R5 SON H, HALO, CN, NO2, -OC(=O)ORb, ENTRE OTROS; R6 ES ARILO C6-C10, ARILOXI C6-C10, HETEROARILOXI C2-C5, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 9-AMINO-5-(2-FLUORO-6-METOXIFENIL)-2-(4-METOXIBENCIL)-2,3-DIHIDROPIRROLO[3,4-b]QUINOLIN-1-ONA, 9-AMINO-5-(2,5-DIFLUOROFENIL)-2-(4-METOXIBENCIL)-2,3-DIHIDROPIRROLO[3,4-b]QUINOLIN-1-ONA, 9-AMINO-2-(4-METOXIBENCIL)-5-(2-METOXIPIRIDIN-3-IL)-2,3-DIHIDROPIRROLO[3,4-b]QUINOLIN-1-ONA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE LA ACTIVIDAD DEL RECEPTOR GABAA Y SON UTILES EN EL TRATAMIENTO DE ESQUIZOFRENIA, TRASTORNO DE ANSIEDAD, TRASTORNO DEL HUMOR, TRASTORNO DEPRESIVO, ENTRE OTROS
PE2008001052A 2007-06-19 2008-06-19 Derivados de quinolina como moduladores de gabaa PE20090693A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94487907P 2007-06-19 2007-06-19

Publications (1)

Publication Number Publication Date
PE20090693A1 true PE20090693A1 (es) 2009-07-17

Family

ID=40084145

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001052A PE20090693A1 (es) 2007-06-19 2008-06-19 Derivados de quinolina como moduladores de gabaa

Country Status (15)

Country Link
US (1) US20080318943A1 (es)
EP (1) EP2176263A2 (es)
JP (1) JP2010530405A (es)
KR (1) KR20100039339A (es)
CN (1) CN101778849A (es)
AR (1) AR067027A1 (es)
AU (1) AU2008264984A1 (es)
BR (1) BRPI0813379A2 (es)
CA (1) CA2691237A1 (es)
CL (1) CL2008001838A1 (es)
MX (1) MX2009013885A (es)
PE (1) PE20090693A1 (es)
TW (1) TW200904817A (es)
UY (1) UY31159A1 (es)
WO (1) WO2008155572A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX341704B (es) * 2009-10-26 2016-08-31 Signal Pharm Llc Métodos de síntesis y purificación de compuestos de heteroarilo.
WO2014127214A1 (en) 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
US9353123B2 (en) 2013-02-20 2016-05-31 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
WO2015066482A1 (en) 2013-11-01 2015-05-07 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
GB201322334D0 (en) 2013-12-17 2014-01-29 Agency Science Tech & Res Maleimide derivatives as modulators of WNT pathway
TWI758241B (zh) 2015-01-13 2022-03-21 日商日產化學工業股份有限公司 反應混合物中之錫化合物之處理方法
KR20190051010A (ko) 2016-09-08 2019-05-14 칼라 파마슈티컬스, 인크. 치료 화합물의 결정형 및 그의 용도
EP3509423A4 (en) 2016-09-08 2020-05-13 Kala Pharmaceuticals, Inc. CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
US10253036B2 (en) 2016-09-08 2019-04-09 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN108863917A (zh) * 2017-05-16 2018-11-23 穆云 一种2,5-二甲氧基吡啶的制备方法
ES2876290T3 (es) * 2017-06-27 2021-11-12 Bayer Ag Procedimiento para preparar los derivados de 4-aminoindano sustituidos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK268979A (da) * 1979-01-22 1980-07-23 Lilly Co Eli Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner
GB8610980D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
US5190951A (en) * 1990-10-19 1993-03-02 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US5240934A (en) * 1990-10-19 1993-08-31 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
RU2257385C2 (ru) * 2003-08-26 2005-07-27 ООО "Исследовательский институт химического разнообразия" 1,3-диоксо -2,3-дигидро-1h-пирроло[3,4-c]хинолины (варианты), фармацевтические композиции (варианты), способ их получения (варианты) и способы лечения (варианты)

Also Published As

Publication number Publication date
CL2008001838A1 (es) 2009-03-06
CN101778849A (zh) 2010-07-14
EP2176263A2 (en) 2010-04-21
KR20100039339A (ko) 2010-04-15
MX2009013885A (es) 2010-01-27
WO2008155572A3 (en) 2009-02-26
BRPI0813379A2 (pt) 2014-12-30
AU2008264984A1 (en) 2008-12-24
UY31159A1 (es) 2009-01-30
CA2691237A1 (en) 2008-12-24
WO2008155572A2 (en) 2008-12-24
AR067027A1 (es) 2009-09-30
US20080318943A1 (en) 2008-12-25
TW200904817A (en) 2009-02-01
JP2010530405A (ja) 2010-09-09

Similar Documents

Publication Publication Date Title
PE20090693A1 (es) Derivados de quinolina como moduladores de gabaa
PE20080067A1 (es) DERIVADOS DE TRIAZOLOPIRAZINA COMO MODULADORES DEL RECEPTOR DEL FACTOR DE CRECIMIENTO DE HEPATOCITO (c-MET O HGFR)
PE20130525A1 (es) Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih
PE20060241A1 (es) 2-quinolil-oxazoles sustituidos como inhibidores de pde4
PE20171514A1 (es) Heterociclos biciclicos como inhibidores de fgfr
PE20121815A1 (es) Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6
PE20141041A1 (es) Compuestos, metodos y formulaciones parasiticidas
PE20081345A1 (es) Compuestos heterociclicos que contienen nitrogeno como agonistas del receptor nicotinico
PE20141307A1 (es) Aril dihidropiridinona y piperidinona como inhibidores de monoacilglicerol aciltransferasa (mgat2)
PE20090326A1 (es) Compuestos heterociclos como inhibidores de erk
PE20110588A1 (es) Derivados de benzotiazol como agentes anticancerigenos
PE20141281A1 (es) Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a
PE20160664A1 (es) Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina
PE20131165A1 (es) Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral
EA030199B9 (ru) Терапевтически активные соединения и способы их применения
PE20130010A1 (es) Derivado de 1,3,4,8-tetrahidro-2h-pirido[1,2-a]pirazina como inhibidor de la integrasa del vih
PE20141110A1 (es) Derivados heterociclicos novedosos para el tratamiento de trastornos neurologicos
PE20091103A1 (es) Inhibidores de la polimerasa virica
PE20201165A1 (es) Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
PE20121180A1 (es) (heteroarilmetil) tiohidantoinas sustituidas como drogas anticancer
PE20080552A1 (es) Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa
PE20141308A1 (es) Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a
PE20130279A1 (es) Compuestos heteroarilo nitrogenados
PE20120995A1 (es) Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral
PE20121118A1 (es) Compuestos de haloalquil heteroaril benzamida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal